Literature DB >> 20414208

Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells.

Christopher K Glass1, Kaoru Saijo.   

Abstract

Members of the nuclear receptor superfamily of ligand-dependent transcription factors regulate diverse aspects of immunity and inflammation by both positively and negatively regulating gene expression. Here, we review recent studies providing insights into the distinct mechanisms that enable nuclear receptors to antagonize pro-inflammatory programmes of gene expression in macrophages and T cells by altering the turnover or recruitment of co-repressors and co-activators in a gene-specific manner. These nuclear receptor-dependent transrepression pathways are proposed to have roles in controlling the initiation, magnitude and duration of pro-inflammatory gene expression and are amenable to pharmacological manipulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20414208     DOI: 10.1038/nri2748

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  78 in total

Review 1.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

2.  Estrogen down-regulation of the corepressor N-CoR: mechanism and implications for estrogen derepression of N-CoR-regulated genes.

Authors:  Jonna Frasor; Jeanne M Danes; Cory C Funk; Benita S Katzenellenbogen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-01       Impact factor: 11.205

3.  FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription.

Authors:  Mathieu Lupien; Jérôme Eeckhoute; Clifford A Meyer; Qianben Wang; Yong Zhang; Wei Li; Jason S Carroll; X Shirley Liu; Myles Brown
Journal:  Cell       Date:  2008-03-21       Impact factor: 41.582

4.  Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages.

Authors:  Yury I Miller; Suganya Viriyakosol; Dorothy S Worrall; Agnès Boullier; Susan Butler; Joseph L Witztum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-02-17       Impact factor: 8.311

5.  The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

Authors:  Ivaylo I Ivanov; Brent S McKenzie; Liang Zhou; Carlos E Tadokoro; Alice Lepelley; Juan J Lafaille; Daniel J Cua; Dan R Littman
Journal:  Cell       Date:  2006-09-22       Impact factor: 41.582

6.  Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation.

Authors:  M Maira; C Martens; A Philips; J Drouin
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

7.  Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease.

Authors:  Silke Walter; Maryse Letiembre; Yang Liu; Holger Heine; Botond Penke; Wenlin Hao; Barbara Bode; Nicole Manietta; Jessica Walter; Walter Schulz-Schuffer; Klaus Fassbender
Journal:  Cell Physiol Biochem       Date:  2007

8.  Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid.

Authors:  Daniel Mucida; Yunji Park; Gisen Kim; Olga Turovskaya; Iain Scott; Mitchell Kronenberg; Hilde Cheroutre
Journal:  Science       Date:  2007-06-14       Impact factor: 47.728

9.  A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor.

Authors:  Florian Blaschke; Yasunori Takata; Evren Caglayan; Alan Collins; Peter Tontonoz; Willa A Hsueh; Rajendra K Tangirala
Journal:  Circ Res       Date:  2006-11-16       Impact factor: 17.367

10.  Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR.

Authors:  Noelia A-Gonzalez; Steven J Bensinger; Cynthia Hong; Susana Beceiro; Michelle N Bradley; Noam Zelcer; Jose Deniz; Cristina Ramirez; Mercedes Díaz; German Gallardo; Carlos Ruiz de Galarreta; Jon Salazar; Felix Lopez; Peter Edwards; John Parks; Miguel Andujar; Peter Tontonoz; Antonio Castrillo
Journal:  Immunity       Date:  2009-07-30       Impact factor: 31.745

View more
  284 in total

1.  Peroxisome proliferator-activated receptor-γ agonists repress epithelial sodium channel expression in the kidney.

Authors:  Emily Borsting; Vicki Pei-Chun Cheng; Chris K Glass; Volker Vallon; Robyn Cunard
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-14

2.  Ligand-independent phosphorylation of the glucocorticoid receptor integrates cellular stress pathways with nuclear receptor signaling.

Authors:  Amy Jo Galliher-Beckley; Jason Grant Williams; John Anthony Cidlowski
Journal:  Mol Cell Biol       Date:  2011-09-19       Impact factor: 4.272

Review 3.  General molecular biology and architecture of nuclear receptors.

Authors:  Michal Pawlak; Philippe Lefebvre; Bart Staels
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

4.  SMRTε, a corepressor variant, interacts with a restricted subset of nuclear receptors, including the retinoic acid receptors α and β.

Authors:  Brenda J Mengeling; Michael L Goodson; William Bourguet; Martin L Privalsky
Journal:  Mol Cell Endocrinol       Date:  2012-01-12       Impact factor: 4.102

5.  Alternative mRNA splicing of corepressors generates variants that play opposing roles in adipocyte differentiation.

Authors:  Michael L Goodson; Brenda J Mengeling; Brian A Jonas; Martin L Privalsky
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

6.  A comprehensive view of nuclear receptor cancer cistromes.

Authors:  Qianzi Tang; Yiwen Chen; Clifford Meyer; Tim Geistlinger; Mathieu Lupien; Qian Wang; Tao Liu; Yong Zhang; Myles Brown; Xiaole Shirley Liu
Journal:  Cancer Res       Date:  2011-09-22       Impact factor: 12.701

Review 7.  Inflammatory signaling in macrophages: transitions from acute to tolerant and alternative activation states.

Authors:  Lionel B Ivashkiv
Journal:  Eur J Immunol       Date:  2011-09       Impact factor: 5.532

8.  PPARγ-activation increases intestinal M1 macrophages and mitigates formation of serrated adenomas in mutant KRAS mice.

Authors:  Tobias Gutting; Christian A Weber; Philip Weidner; Frank Herweck; Sarah Henn; Teresa Friedrich; Shuiping Yin; Julia Kzhyshkowska; Timo Gaiser; Klaus-Peter Janssen; Wolfgang Reindl; Matthias P A Ebert; Elke Burgermeister
Journal:  Oncoimmunology       Date:  2018-02-01       Impact factor: 8.110

Review 9.  PPARγ in head and neck cancer prevention.

Authors:  Mauricio Burotto; Eva Szabo
Journal:  Oral Oncol       Date:  2014-01-13       Impact factor: 5.337

10.  RON receptor tyrosine kinase, a negative regulator of inflammation, is decreased during simian immunodeficiency virus-associated central nervous system disease.

Authors:  Daniele C Cary; Janice E Clements; Andrew J Henderson
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.